Magnetic resonance-guided histopathology for improved accuracy of tumor response evaluation of neoadjuvant treatment in organ-infiltrating rectal cancer

Radiotherapy and Oncology

Volumn 107, Issue 2, 2013, Pages 178-183

  Hole, Knut Håkon ^a,c   Larsen, Stein Gunnar ^a   Grøholt, Krystyna Kotanska ^a   Giercksky, Karl Erik ^a,c   Ree, Anne Hansen ^b,c  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^c UNIVERSITY OF OSLO   (Norway)

Author keywords

Histopathology; Locally advanced; Magnetic resonance; Radiotherapy chemoradiotherapy; Rectal cancer; Response evaluation

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CHEMORADIOTHERAPY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE GUIDED RADIOTHERAPY; MAJOR CLINICAL STUDY; MALE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RECTUM CANCER; TISSUE SECTION; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 84879031699     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.03.017     Document Type: Article

References (30)

1. V. Valentini, R. Beets-Tan, and J.M. Borras Evidence and research in rectal cancer Radiother Oncol 87 2008 449 474
2. MERCURY Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. BMJ 2006. 10.1136/bmj.38937.646400.55. (Pubitemid 44583356)
3. C. Capirci, V. Valentini, and L. Cionini Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: long-term analysis of 566 ypCR patients Int J Radiat Oncol Biol Phys 72 2008 99 107
4. J.G. Guillem, D.B. Chessin, and A.M. Cohen Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer Ann Surg 241 2005 829 838 (Pubitemid 40604929)
5. M. Maas, P.J. Nelemans, and V. Valentini Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer: a pooled analysis of individual patient data Lancet Oncol 11 2010 835 844
6. A. Habr-Gama, R.O. Perez, and W. Nadalin Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results Ann Surg 240 2004 711 717
7. A. Habr-Gama, R.O. Perez, G.P. São Julião, I. Proscurshim, and J. Gama-Rodrigues Nonoperative approaches to rectal cancer: a critical evaluation Semin Radiat Oncol 21 2011 234 239
8. M. Maas, R.G. Beets-Tan, and D.M. Lambregts Wait-and-see policy for clinical complete responders after chemoradiation for rectal cancer J Clin Oncol 29 2011 4633 4640
9. J.N. Wiig, S.G. Larsen, S. Dueland, and K.E. Giercksky Clinical outcome in patients with complete pathologic response (pT0) to preoperative irradiation/chemo-irradiation operated for locally advanced or locally recurrent rectal cancer J Surg Oncol 92 2005 70 75 (Pubitemid 41416431)
10. C. Coco, V. Valentini, and A. Manno Long-term results after neoadjuvant radiochemotherapy for locally advanced resectable extraperitoneal rectal cancer Dis Colon Rectum 49 2006 311 318
11. S.G. Larsen, J.N. Wiig, and H.L. Emblemsvaag Extended total mesorectal excision in locally advanced rectal cancer (T4a) and the clinical role of MRI-evaluated neo-adjuvant downstaging Colorectal Dis 11 2009 759 767
12. P. Quirke, P. Durdey, M.F. Dixon, and N.S. Williams Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Histopathological study of lateral tumour spread and surgical excision Lancet 2 1986 996 999 (Pubitemid 16005611)
13. P. Quirke, and M.F. Dixon The prediction of local recurrence in rectal adenocarcinoma by histopathological examination Int J Colorectal Dis 3 1988 127 131
14. H. Bouzourene, F.T. Bosman, W. Seelentag, M. Matter, and P. Coucke Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy Cancer 94 2002 1121 1130 (Pubitemid 34150868)
15. R.F. Vliegen, G.L. Beets, and G. Lammering Mesorectal fascia invasion after neoadjuvant chemotherapy and radiation therapy for locally advanced rectal cancer: accuracy of MR imaging for prediction Radiology 246 2008 454 462
16. J. Evans, D. Tait, and I. Swift Timing of surgery following preoperative therapy in rectal cancer: the need for a prospective randomized trial? Dis Colon Rectum 54 2011 1251 1259
17. H.G. Moore, A.E. Gittleman, and B.D. Minsky Rate of pathologic complete response with increased interval between preoperative combined modality therapy and rectal cancer resection Dis Colon Rectum 47 2004 279 286 (Pubitemid 38280578)
18. H. Tulchinsky, E. Shmueli, A. Figer, J.M. Klausner, and K. Rabau An interval >7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer Ann Surg Oncol 15 2008 2661 2667
19. Y. Wang, B. Cummings, and P. Catton Primary radical external beam radiotherapy of rectal adenocarcinoma: long term outcome of 271 patients Radiother Oncol 77 2005 126 131
20. D. Helbling, G. Bodoky, and O. Gautschi Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS, locally advanced rectal cancer (LARC): a randomized, multicenter, phase II trial SAKK 41/07 Ann Oncol 24 2013 718 725
21. J.D. Smith, G.M. Nash, M.R. Weiser, L.K. Temple, J.G. Guillem, and P.B. Paty Multivisceral resections for rectal cancer Br J Cancer 99 2012 1137 1143
22. S.H. Petersen, H. Harling, L.T. Kirkeby, P. Wille-Jørgensen, and S. Mocellin Postoperative adjuvant chemotherapy in rectal cancer operated for cure Cochrane Database Syst Rev 3 2012 CD004078
23. L. Curvo-Semedo, D.M. Lambregts, and M. Maas Rectal cancer: assessment of complete response to preoperative combined radiation therapy with chemotherapy - conventional MR volumetry versus diffusion-weighted MR imaging Radiology 260 2011 734 743
24. S.H. Kim, J.Y. Lee, J.M. Lee, J.K. Han, and B.I. Choi Apparent diffusion coefficient for evaluating tumour response to neoadjuvant chemoradiation therapy for locally advanced rectal cancer Eur Radiol 21 2011 987 995
25. M. Lambrecht, V. Vandecaveye, and F. De Keyzer Value of diffusion-weighted magnetic resonance imaging for prediction and early assessment of response to neoadjuvant radiochemotherapy in rectal cancer: preliminary results Int J Radiat Oncol Biol Phys 82 2012 863 870
26. D.M. Lambregts, V. Vandecaveye, and B. Barbaro Diffusion-weighted MRI for selection of complete responders after chemoradiation for locally advanced rectal cancer: a multicenter study Ann Surg Oncol 18 2011 2224 2231
27. G.V. Salerno, I.R. Daniels, B.J. Moran, R.J. Heald, K. Thomas, and G. Brown Magnetic resonance imaging prediction of an involved surgical resection margin in low rectal cancer Dis Colon Rectum 52 2009 632 639
28. U.B. Patel, F. Taylor, and L. Blomqvist Magnetic resonance imaging-detected tumor response for locally advanced rectal cancer predicts survival outcomes: MERCURY experience J Clin Oncol 29 2011 3753 3760
29. M. Lambrecht, C. Deroose, and S. Roels The use of FDG-PET/CT and diffusion-weighted magnetic resonance imaging for response prediction before, during and after preoperative chemoradiotherapy for rectal cancer Acta Oncol 49 2010 956 963
30. B. Barbaro, C. Fiorucci, and C. Tebala Locally advanced rectal cancer: MR imaging in prediction of response after preoperative chemotherapy and radiation therapy Radiology 250 2009 730 739